Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Best starting flow for high-flow nasal cannula after extubation

Official title: Optimizing High-flow Nasal Cannula Settings: Comparing Different Flow Approaches and Exploring Physiological Phenotyping With End-expiratory Lung Volume, Peak Tidal Inspiratory Flow and Oxygen Demand

Run by National Taiwan University Hospital · NCT07007715 · Data updated 2026-11-12

This trial tests four different ways of setting the initial flow on high-flow nasal cannula to see if one approach reduces breathing problems or the need to be put back on a ventilator after adults are extubated.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment480 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedJune 5, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedJuly 20, 2026
Trial IDNCT07007715 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults intubated and mechanically ventilated for more than 24 hours who have passed a spontaneous breathing trial and are ready for planned extubation with PaO2/FiO2 <350 mmHg are ideal candidates.

Probably not a fit

Patients with tracheostomies, those planned to receive preventive NIV after extubation, those with do-not-reintubate orders, pregnant patients, children, or anyone for whom HFNC is infeasible are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, 4-arm parallel-group trial comparing four HFNC flow-setting strategies after planned extubation: fixed 40 L/min, fixed 60 L/min, a peak tidal inspiratory flow (PTIF)-guided setting (5 L/min above PTIF up to 60 L/min), and a PaO2/FiO2 (P/F)-guided tiered flow (60/50/40 L/min by P/F ranges). Eligible adult patients have been mechanically ventilated >24 hours, passed a spontaneous breathing trial, and have PaO2/FiO2 <350 mmHg at extubation. The trial will collect physiological measures including PTIF and end-expiratory lung volume (EELV) and track extubation outcomes such as need for reintubation. The goal is to determine whether physiology-guided or simple fixed-flow approaches lead to better post-extubation results and tolerability.

Why it matters

Potential benefit: If successful, the results could help clinicians choose an initial HFNC flow that lowers reintubation risk, improves breathing comfort, and avoids unnecessary high flows.

How similar studies have gone: Previous studies show HFNC can improve oxygenation and reduce work of breathing versus conventional oxygen, but randomized comparisons of specific flow-setting strategies like PTIF- or P/F-guided approaches are limited, so this question is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intubated and receiving mechanical ventilation for more than 24 hours
* Ready for planned extubation after passing a spontaneous breathing trial
* PaO2/FiO2 \<350 mmHg on the day of extubation

Exclusion Criteria:

* Age \<18 years
* On do-not-reintubate code
* Pregnant women
* Having tracheostomies
* Infeasibility of using HFNC
* Planning to use preventive NIV after extubation by the primary care team
* Life expectancy less than one month

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.